PortalPublikationenMulticenter Analysis of Endovascular Aortic Arch In Situ Ste...

Multicenter Analysis of Endovascular Aortic Arch In Situ Stent-Graft Fenestrations for Aortic Arch Pathologies

Standard

Multicenter Analysis of Endovascular Aortic Arch In Situ Stent-Graft Fenestrations for Aortic Arch Pathologies. / Kopp, Reinhard; Katada, Yoshiaki; Kondo, Shunichi; Sonesson, Björn; Hongo, Norio; Tse, Leonard; Tsilimparis, Nikolaos; Crawford, Sean; Panneton, Jean M; Kölbel, Tilo; Xiong, Jiang; Guo, Wei; Kasprzak, Piotr M; AARCHIF registry.

in: ANN VASC SURG, Jahrgang 59, 08.2019, S. 36-47.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Kopp, R, Katada, Y, Kondo, S, Sonesson, B, Hongo, N, Tse, L, Tsilimparis, N, Crawford, S, Panneton, JM, Kölbel, T, Xiong, J, Guo, W, Kasprzak, PM & AARCHIF registry 2019, 'Multicenter Analysis of Endovascular Aortic Arch In Situ Stent-Graft Fenestrations for Aortic Arch Pathologies', ANN VASC SURG, Jg. 59, S. 36-47. https://doi.org/10.1016/j.avsg.2019.02.005

APA

Kopp, R., Katada, Y., Kondo, S., Sonesson, B., Hongo, N., Tse, L., Tsilimparis, N., Crawford, S., Panneton, J. M., Kölbel, T., Xiong, J., Guo, W., Kasprzak, P. M., & AARCHIF registry (2019). Multicenter Analysis of Endovascular Aortic Arch In Situ Stent-Graft Fenestrations for Aortic Arch Pathologies. ANN VASC SURG, 59, 36-47. https://doi.org/10.1016/j.avsg.2019.02.005

Vancouver

Kopp R, Katada Y, Kondo S, Sonesson B, Hongo N, Tse L et al. Multicenter Analysis of Endovascular Aortic Arch In Situ Stent-Graft Fenestrations for Aortic Arch Pathologies. ANN VASC SURG. 2019 Aug;59:36-47. https://doi.org/10.1016/j.avsg.2019.02.005

Bibtex

@article{a0b1d4dcff574d8982e9f752411072b6,
title = "Multicenter Analysis of Endovascular Aortic Arch In Situ Stent-Graft Fenestrations for Aortic Arch Pathologies",
abstract = "BACKGROUND: In situ fenestration of aortic stent grafts for treatment of aortic arch aneurysms is a new option for endovascular aortic arch repair. So far, only few reports have shown perioperative and short-term results of in situ fenestrations for aortic arch diseases. We present the multicenter experience with the aortic arch in situ fenestration technique documented in the AARCHIF registry for treatment of aortic arch aneurysms or localized type A aortic dissections and analyzed perioperative outcome and midterm follow-up.METHODS: Patients with aortic arch pathologies treated by aortic arch in situ fenestration with proximal stent graft landing in aortic arch Ishimura zones 0 and 1 were included in the registry. Stent-graft in situ fenestrations were created using needles or radiofrequency or laser catheters and completed by implantation of covered connecting stent grafts. Single in situ fenestrations for the left subclavian artery (LSA) were excluded.RESULTS: Between 06/2009 and 03/2017, twenty-five patients were treated by in situ stent-graft fenestrations for aortic arch pathologies at 9 institutions in 7 different countries, 3 of them as bailout procedures for stent-graft malplacement. In situ fenestrations were performed for the brachiocephalic trunk (n = 20), the left common carotid artery (n = 21) and the LSA (n = 9). Technical success for intended in situ fenestrations was 94.0% (47/50), with additional supraaortic bypass procedures performed in 14 patients. Perioperative mortality occurred in 1 (4.0%) patient, treated as a bailout procedure and 3 (12.0%) perioperative strokes were observed. One proximal aortic stent-graft nonalignment and 4 type III endoleaks, 2 early and 2 late, required reeintervention. During follow-up (1-118 months), the diameter of aortic arch aneurysms decreased from 61.5 ± 4.1 mm to 48.4 ± 3.2 mm (P = 0.02) and, so far, 6 patients died from diseases unrelated to their aortic arch pathologies with a mean survival time of 79.5 months and 3 endovascular reinterventions for distal aortic expansion were performed. Cerebrovascular event (n = 4) was the most relevant prognostic factor for mortality during midterm follow-up (P = 0.003).CONCLUSIONS: The aortic arch in situ fenestration technique for endovascular aortic arch repair seems to be valuable treatment option for selected patients, although initial consideration of other treatment options is mandatory. Data about long-term durability are required.",
keywords = "Adult, Aged, Aged, 80 and over, Aneurysm, Dissecting/diagnostic imaging, Aortic Aneurysm, Thoracic/diagnostic imaging, Aortography/methods, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation/adverse effects, Computed Tomography Angiography, Endovascular Procedures/adverse effects, Female, Humans, Male, Middle Aged, Postoperative Complications/etiology, Prosthesis Design, Registries, Retrospective Studies, Risk Assessment, Risk Factors, Stents, Time Factors, Treatment Outcome",
author = "Reinhard Kopp and Yoshiaki Katada and Shunichi Kondo and Bj{\"o}rn Sonesson and Norio Hongo and Leonard Tse and Nikolaos Tsilimparis and Sean Crawford and Panneton, {Jean M} and Tilo K{\"o}lbel and Jiang Xiong and Wei Guo and Kasprzak, {Piotr M} and {AARCHIF registry}",
note = "Copyright {\textcopyright} 2019. Published by Elsevier Inc.",
year = "2019",
month = aug,
doi = "10.1016/j.avsg.2019.02.005",
language = "English",
volume = "59",
pages = "36--47",
journal = "ANN VASC SURG",
issn = "0890-5096",
publisher = "Elsevier Inc.",

}

RIS

TY - JOUR

T1 - Multicenter Analysis of Endovascular Aortic Arch In Situ Stent-Graft Fenestrations for Aortic Arch Pathologies

AU - Kopp, Reinhard

AU - Katada, Yoshiaki

AU - Kondo, Shunichi

AU - Sonesson, Björn

AU - Hongo, Norio

AU - Tse, Leonard

AU - Tsilimparis, Nikolaos

AU - Crawford, Sean

AU - Panneton, Jean M

AU - Kölbel, Tilo

AU - Xiong, Jiang

AU - Guo, Wei

AU - Kasprzak, Piotr M

AU - AARCHIF registry

N1 - Copyright © 2019. Published by Elsevier Inc.

PY - 2019/8

Y1 - 2019/8

N2 - BACKGROUND: In situ fenestration of aortic stent grafts for treatment of aortic arch aneurysms is a new option for endovascular aortic arch repair. So far, only few reports have shown perioperative and short-term results of in situ fenestrations for aortic arch diseases. We present the multicenter experience with the aortic arch in situ fenestration technique documented in the AARCHIF registry for treatment of aortic arch aneurysms or localized type A aortic dissections and analyzed perioperative outcome and midterm follow-up.METHODS: Patients with aortic arch pathologies treated by aortic arch in situ fenestration with proximal stent graft landing in aortic arch Ishimura zones 0 and 1 were included in the registry. Stent-graft in situ fenestrations were created using needles or radiofrequency or laser catheters and completed by implantation of covered connecting stent grafts. Single in situ fenestrations for the left subclavian artery (LSA) were excluded.RESULTS: Between 06/2009 and 03/2017, twenty-five patients were treated by in situ stent-graft fenestrations for aortic arch pathologies at 9 institutions in 7 different countries, 3 of them as bailout procedures for stent-graft malplacement. In situ fenestrations were performed for the brachiocephalic trunk (n = 20), the left common carotid artery (n = 21) and the LSA (n = 9). Technical success for intended in situ fenestrations was 94.0% (47/50), with additional supraaortic bypass procedures performed in 14 patients. Perioperative mortality occurred in 1 (4.0%) patient, treated as a bailout procedure and 3 (12.0%) perioperative strokes were observed. One proximal aortic stent-graft nonalignment and 4 type III endoleaks, 2 early and 2 late, required reeintervention. During follow-up (1-118 months), the diameter of aortic arch aneurysms decreased from 61.5 ± 4.1 mm to 48.4 ± 3.2 mm (P = 0.02) and, so far, 6 patients died from diseases unrelated to their aortic arch pathologies with a mean survival time of 79.5 months and 3 endovascular reinterventions for distal aortic expansion were performed. Cerebrovascular event (n = 4) was the most relevant prognostic factor for mortality during midterm follow-up (P = 0.003).CONCLUSIONS: The aortic arch in situ fenestration technique for endovascular aortic arch repair seems to be valuable treatment option for selected patients, although initial consideration of other treatment options is mandatory. Data about long-term durability are required.

AB - BACKGROUND: In situ fenestration of aortic stent grafts for treatment of aortic arch aneurysms is a new option for endovascular aortic arch repair. So far, only few reports have shown perioperative and short-term results of in situ fenestrations for aortic arch diseases. We present the multicenter experience with the aortic arch in situ fenestration technique documented in the AARCHIF registry for treatment of aortic arch aneurysms or localized type A aortic dissections and analyzed perioperative outcome and midterm follow-up.METHODS: Patients with aortic arch pathologies treated by aortic arch in situ fenestration with proximal stent graft landing in aortic arch Ishimura zones 0 and 1 were included in the registry. Stent-graft in situ fenestrations were created using needles or radiofrequency or laser catheters and completed by implantation of covered connecting stent grafts. Single in situ fenestrations for the left subclavian artery (LSA) were excluded.RESULTS: Between 06/2009 and 03/2017, twenty-five patients were treated by in situ stent-graft fenestrations for aortic arch pathologies at 9 institutions in 7 different countries, 3 of them as bailout procedures for stent-graft malplacement. In situ fenestrations were performed for the brachiocephalic trunk (n = 20), the left common carotid artery (n = 21) and the LSA (n = 9). Technical success for intended in situ fenestrations was 94.0% (47/50), with additional supraaortic bypass procedures performed in 14 patients. Perioperative mortality occurred in 1 (4.0%) patient, treated as a bailout procedure and 3 (12.0%) perioperative strokes were observed. One proximal aortic stent-graft nonalignment and 4 type III endoleaks, 2 early and 2 late, required reeintervention. During follow-up (1-118 months), the diameter of aortic arch aneurysms decreased from 61.5 ± 4.1 mm to 48.4 ± 3.2 mm (P = 0.02) and, so far, 6 patients died from diseases unrelated to their aortic arch pathologies with a mean survival time of 79.5 months and 3 endovascular reinterventions for distal aortic expansion were performed. Cerebrovascular event (n = 4) was the most relevant prognostic factor for mortality during midterm follow-up (P = 0.003).CONCLUSIONS: The aortic arch in situ fenestration technique for endovascular aortic arch repair seems to be valuable treatment option for selected patients, although initial consideration of other treatment options is mandatory. Data about long-term durability are required.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Aneurysm, Dissecting/diagnostic imaging

KW - Aortic Aneurysm, Thoracic/diagnostic imaging

KW - Aortography/methods

KW - Blood Vessel Prosthesis

KW - Blood Vessel Prosthesis Implantation/adverse effects

KW - Computed Tomography Angiography

KW - Endovascular Procedures/adverse effects

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Postoperative Complications/etiology

KW - Prosthesis Design

KW - Registries

KW - Retrospective Studies

KW - Risk Assessment

KW - Risk Factors

KW - Stents

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1016/j.avsg.2019.02.005

DO - 10.1016/j.avsg.2019.02.005

M3 - SCORING: Journal article

C2 - 31009715

VL - 59

SP - 36

EP - 47

JO - ANN VASC SURG

JF - ANN VASC SURG

SN - 0890-5096

ER -